tradingkey.logo

Bio-Techne Corp

TECH
查看详细走势图
57.971USD
-0.539-0.92%
交易中 美东报价延迟15分钟
9.03B总市值
116.08市盈率 TTM

Bio-Techne Corp

57.971
-0.539-0.92%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.92%

5天

-6.01%

1月

-2.37%

6月

+14.75%

今年开始到现在

-19.52%

1年

-23.41%

查看详细走势图

TradingKey Bio-Techne Corp股票评分

单位: USD 更新时间: 2025-12-12

操作建议

Bio-Techne Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名49/404位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价69.40。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bio-Techne Corp评分

相关信息

行业排名
49 / 404
全市场排名
144 / 4592
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 17 位分析师
买入
评级
69.402
目标均价
+15.11%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Bio-Techne Corp亮点

亮点风险
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
高分红
公司属于高分红公司,最新股息支付率68.69%
稳定分红
公司5年内连续分红,最新股息支付率68.69%
估值高估
公司最新PE估值117.16,处于3年历史高位
机构减仓
最新机构持股161.18M股,环比减少4.35%
ETHSX持仓
明星投资者ETHSX持仓,最新持仓市值93.35K

Bio-Techne Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bio-Techne Corp简介

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
公司代码TECH
公司Bio-Techne Corp
CEOKelderman (Kim)
网址https://www.bio-techne.com/

常见问题

Bio-Techne Corp(TECH)的当前股价是多少?

Bio-Techne Corp(TECH)的当前股价是 57.971。

Bio-Techne Corp的股票代码是什么?

Bio-Techne Corp的股票代码是TECH。

Bio-Techne Corp股票的52周最高点是多少?

Bio-Techne Corp股票的52周最高点是79.280。

Bio-Techne Corp股票的52周最低点是多少?

Bio-Techne Corp股票的52周最低点是46.010。

Bio-Techne Corp的市值是多少?

Bio-Techne Corp的市值是9.03B。

Bio-Techne Corp的净利润是多少?

Bio-Techne Corp的净利润为73.36M。

现在Bio-Techne Corp(TECH)的股票是买入、持有还是卖出?

根据分析师评级,Bio-Techne Corp(TECH)的总体评级为买入,目标价格为69.402。

Bio-Techne Corp(TECH)股票的每股收益(EPS TTM)是多少

Bio-Techne Corp(TECH)股票的每股收益(EPS TTM)是0.499。
KeyAI